United Kingdom · Funded startup

Who invested in AstronauTx

6 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 2 months ago

Funding summaryUpdated 26 Oct 2026

$124Mraised across 6 rounds since 2019, from 6 sources

$7.8MRound$61MSeries A$6.5MSeries A$23MSeries A$25MSeries A$1.2MGrant
Latest round
Grant, $1.2MSept 2026
Biggest round
$61MSeries A · Oct 2023
Investors
9 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020202120222023202420252026
$7.8MRound$61MSeries A$6.5MSeries A$23MSeries A$25MSeries A$1.2MGrant
First round
Round, $7.8M
Aug 2019
Biggest round
$61M
Series A · Oct 2023
Usual gap between rounds
9 months
the median of 5

The rounds

  1. Sept 2026
    Grant$1.2M3 returning

    Source recorded

  2. Jan 2026
    Series A$25M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Dec 2024
    Series A$23M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  4. Jul 2024
    Series A$6.5M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  5. Oct 2023
  6. Aug 2019
    Round$7.8M1 new
    • The Dementia Discovery Fund

    Reported by Standard

Funding filed with regulators

AstronauTx filed 6 raises, $77M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Aug 2026$5.0MUK share allotment
  2. Jan 2026$25MUK share allotment
  3. Dec 2024$23MUK share allotment
  4. Jul 2024$6.5MUK share allotment
  5. Oct 2023$3.4MUK share allotment
  6. Aug 2023$15MUK share allotment

Founders and team

From AstronauTx's own website: 2 on the team.

  • Angela CartwrightUS Executive Administrator and Operations Coordinator
  • Deborah GouveiaVP, Clinical Operations and Development Strategy

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2019Series A2023Series A2024Series A2024Series A2026Grant2026Innovate UKEQT Life SciencesEQTNovartis Venture FundLMPM CapitalBrandon CapitalBristol Myers SquibbDementia Discovery FundThe Dementia Discovery Fund

Everyone who backed them

Innovate UKVC firm2rounds
EQT Life SciencesVC firm2rounds
EQTPrivate equity2rounds
Novartis Venture FundCorporate VC1round, led 1
MPM CapitalPrivate equity1round
Brandon CapitalVC firm1round
The Dementia Discovery Fundno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists AstronauTx as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

UCL Technology FundVC firmPer its own site

Quick answers about AstronauTx

Who invested in AstronauTx?

AstronauTx's investors include Innovate UK, EQT Life Sciences, EQT, Novartis Venture Fund and MPM Capital, and 4 more on record.

How much has AstronauTx raised?

AstronauTx has raised $124M across 6 rounds since 2019.

When did AstronauTx last raise?

AstronauTx's most recent round was a Grant of $1.2M in Sept 2026.

What was AstronauTx's biggest round?

AstronauTx's largest round on record is $61M (Series A), in Oct 2023, led by Novartis Venture Fund.

Who backed AstronauTx first?

AstronauTx's first round on record, in Aug 2019, was backed by The Dementia Discovery Fund.

What stage is AstronauTx at?

AstronauTx's latest named round is a Grant, in Sept 2026.

Where is AstronauTx based?

AstronauTx is based in the United Kingdom.

Who led AstronauTx's rounds?

Novartis Venture Fund led the Series A in 2023.

Companies like AstronauTx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.